EVRYS BIO LLC — Department of Defense STTR Phase I: CBD18A-002

EVRYS BIO LLC — STTR Phase I award from Department of Defense.

Amount
$149,997
Agency
Department of Defense · Office for Chemical and Biological Defense
Program / Phase
STTR · Phase I
Topic
CBD18A-002
Solicitation
2018.0
NAICS
Place of performance
PA
Period
2018-09-25 → 2019-03-25

Description

In a pandemic or exposure to weaponized Marburg virus the morbidity, mortality and social unrest that will ensue before vaccines orMilitary operating on foreign soil as well as to the population of the US Homeland. Practically all threat agents of biological origin (except forcertain non-proteinaceous toxins, typically produced by marine organisms and fungi) have their structure and vital function intimatelyintertwined with highly characteristic protein molecules. Detection and characterization of these signature protein molecules can provide anextremely accurate approach to the detection of the threat agents. We propose to develop, prototype and validate a field-portable massspectrometer with associated disposable cartridges for biothreat agents. The system will be capable of detecting all classes of biothreat agentsin cluttered sample matrices. The disposable cartridge will be used to prepare the sample for analysis in the spectrometer. The system isanticipated to have an analysis time of less than 5 minutes and will have a cost per sample of less than $20.